2. 您的位置
3. 首页
4. 期刊论文
5. YKL-40 expression in human hepatocellular carcinoma:a potential biomarker?

YKL-40 expression in human hepatocellular carcinoma:a potential biomarker?

来源 :Hepatobiliary & Pancreatic Diseases International | 被引量 : 0次 | 上传用户：coolzhaonan

【摘 要】

：

BACKGROUND:YKL-40 is a new biomarker with diagnostic value in many different cancers.Whether it may serve as a biomarker for hepatocellular carcinoma (HCC) is s

【作 者】

：

Tarek Hassanein 

【机 构】

：

LiverCenter

【出 处】

：

Hepatobiliary & Pancreatic Diseases International

【发表日期】

：

2011年6期

【关键词】

：

YKL-40 HEPATOCELLULAR CARCINOMA CIRRHOSIS YKL-40 hepatocellular carcinoma cirrho 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

BACKGROUND:YKL-40 is a new biomarker with diagnostic value in many different cancers.Whether it may serve as a biomarker for hepatocellular carcinoma (HCC) is still unclear.This study aimed to examine the expression of YKL-40 in the serum and liver tissue

其他文献

Living donor liver hilar variations: surgical approaches and implications

BACKGROUND: Varied vascular and biliary anatomies are common in the liver. Living donor hepatectomy requires precise recognition of the hilar anatomy. This stud

期刊

LIVINGDONORliverTRANSPLANTATIONANATOMICALvariationliving donor liver tran

Xanthogranulomatous cholecystitis mimicking gallbladder cancer and causing obstructive cholestasis

BACKGROUND: Xanthogranulomatous cholecystitis (XGC) is a destructive inflammatory disease of the gallbladder that can mimic gallbladder carcinoma. METHODS: We p

期刊

XANTHOGRANULOMATOUSCHOLECYSTITISGALLBLADDERcancerOBSTRUCTIVECHOLESTASISxan

Hepatocyte differentiation of human fibroblasts from cirrhotic liver in vitro and in vivo

BACKGROUND:Mesenchymal stem cells(MSCs)and fibro-blasts have intimate relationships,and the phenotypic homology between fibroblasts and MSCs has been recently d

期刊

FIBROBLASTSHEPATOCYTESmesenchymal-epithelialtransitionfibroblasts hepatocyt

Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats

BACKGROUND:Hepatic fibrosis is a necessary step in the development of hepatic cirrhosis.In this study we used lentiviral vector-mediated transfection technology

期刊

PEROXISOMEproliferator-activatedreceptorGAMMAHEPATICFIBROSISHEPATICstella

Clinical management of hepatitis B virus infection correlated with liver transplantation

BACKGROUND:As a radical cure for post-hepatitis B virus (HBV)-related liver cirrhosis and hepatocellular carcinoma,liver transplantation has been applied in man

期刊

HEPATITISBVACCINATIONHEPATITISBIMMUNOGLOBULINLAMIVUDINElivertransplantat

Protective effect of probiotics on intestinal barrier function in malnourished rats after liver tran

BACKGROUND: Most patients waiting for liver transplantation have end-stage liver diseases with malnutrition, which is prone to induce intestinal barrier dysfunc

期刊

liverTRANSPLANTATIONPROBIOTICSINTESTINALMICROFLORAINTESTINALBARRIERfuncti

Fulminant liver failure models with subsequent encephalopathy in the mouse

BACKGROUND:A reliable model of fulminant liver failure (FLF) is urgently required in this research field.This study aimed to develop a murine FLF model.METHODS:

期刊

ANIMALmodelacuteliverfailureAZOXYMETHANEGALACTOSAMINEtumorNECROSISFACTO

Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarc

BACKGROUND:Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an uncommon subtype of primary hepatic carcinoma,and its prognosis is poor.This

期刊

LIVERNEOPLASMSHEPATOCELLULARCARCINOMACHOLANGIOCARCINOMAPROGNOSISstemcells

Evaluation outcomes of donors in living dono liver transplantation: a single-center analysis of 132

BACKGROUND: Donor safety has always been a major concern and potential risk to the donor must be balanced against recipient benefit. However, lack of a standard

期刊

liverTRANSPLANTATIONLIVINGDONORriskFACTORSsafetyliver transplantation li

Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis

BACKGROUND:Cirrhosis is associated with several extrahepatic manifestations including portopulmonary hypertension (PPHT).Recent data suggest that endothelins (E

期刊

CIRRHOSISportopulmonaryHYPERTENSIONENDOTHELINcirrhosisportopulmonary hypert